Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 21
Filter
1.
AJNR Am J Neuroradiol ; 35(3): 498-503, 2014 Mar.
Article in English | MEDLINE | ID: mdl-23988756

ABSTRACT

BACKGROUND AND PURPOSE: A limitation in postoperative monitoring of patients with glioblastoma is the lack of objective measures to quantify residual and recurrent disease. Automated computer-assisted volumetric analysis of contrast-enhancing tissue represents a potential tool to aid the radiologist in following these patients. In this study, we hypothesize that computer-assisted volumetry will show increased precision and speed over conventional 1D and 2D techniques in assessing residual and/or recurrent tumor. MATERIALS AND METHODS: This retrospective study included patients with native glioblastomas with MR imaging performed at 24-48 hours following resection and 2-4 months postoperatively. 1D and 2D measurements were performed by 2 neuroradiologists with Certificates of Added Qualification. Volumetry was performed by using manual segmentation and computer-assisted volumetry, which combines region-based active contours and a level set approach. Tumor response was assessed by using established 1D, 2D, and volumetric standards. Manual and computer-assisted volumetry segmentation times were compared. Interobserver correlation was determined among 1D, 2D, and volumetric techniques. RESULTS: Twenty-nine patients were analyzed. Discrepancy in disease status between 1D and 2D compared with computer-assisted volumetry was 10.3% (3/29) and 17.2% (5/29), respectively. The mean time for segmentation between manual and computer-assisted volumetry techniques was 9.7 minutes and <1 minute, respectively (P < .01). Interobserver correlation was highest for volumetric measurements (0.995; 95% CI, 0.990-0.997) compared with 1D (0.826; 95% CI, 0.695-0.904) and 2D (0.905; 95% CI, 0.828-0.948) measurements. CONCLUSIONS: Computer-assisted volumetry provides a reproducible and faster volumetric assessment of enhancing tumor burden, which has implications for monitoring disease progression and quantification of tumor burden in treatment trials.


Subject(s)
Brain Neoplasms/pathology , Contrast Media , Glioblastoma/pathology , Magnetic Resonance Imaging , Neoplasm Recurrence, Local/pathology , Neuroimaging/methods , Tumor Burden , Adult , Aged , Aged, 80 and over , Female , Humans , Male , Middle Aged , Neoplasm, Residual , Retrospective Studies
2.
Neurology ; 76(3): 236-41, 2011 Jan 18.
Article in English | MEDLINE | ID: mdl-21242491

ABSTRACT

BACKGROUND: Tandutinib (MLN 518, Millennium Pharmaceuticals, Cambridge, MA) is an orally active multitargeted tyrosine kinase inhibitor that is currently under evaluation for the treatment of glioblastoma and has been used in the treatment of leukemia. In prior clinical and animal studies, a dose-dependent muscular weakness has been observed with this drug, though the etiology of the weakness has not been defined. METHODS: Standard neurophysiologic techniques, including repetitive nerve stimulation, needle EMG, and single-fiber EMG, were used to evaluate patients who developed weakness while being treated with tandutinib and bevacizumab (Avastin, Genentech, South San Francisco, CA) for glioblastoma (NCT00667394). RESULTS: Six patients were observed to develop a reversible weakness that correlated with the administration of the tandutinib. The onset of weakness after starting tandutinib occurred within 3 to 112 days and in less than 15 days in 3 patients. Electrophysiologic studies showed that all patients developed abnormal repetitive nerve stimulation studies. Four patients had short duration motor unit potentials. Two of these patients also had abnormal single-fiber EMG, as did a third patient who did not have standard needle EMG. The clinical and electrophysiologic abnormalities improved with the termination or reduction in the dose of tandutinib. CONCLUSION: These observations suggest that tandutinib is toxic to the neuromuscular junction, possibly by reversibly binding to a molecule on the postsynaptic acetylcholine receptor complex. CLASSIFICATION OF EVIDENCE: This study provides Class III evidence that tandutinib 500 mg twice daily induces reversible muscle weakness and electrophysiologic changes consistent with neuromuscular junction dysfunction.


Subject(s)
Myasthenia Gravis/chemically induced , Neuromuscular Junction/drug effects , Piperazines/adverse effects , Protein Kinase Inhibitors/adverse effects , Protein-Tyrosine Kinases/antagonists & inhibitors , Quinazolines/adverse effects , Adult , Aged , Antibodies, Monoclonal/administration & dosage , Antibodies, Monoclonal, Humanized , Antineoplastic Combined Chemotherapy Protocols/adverse effects , Bevacizumab , Brain Neoplasms/drug therapy , Clinical Trials, Phase II as Topic , Drug Administration Schedule , Electromyography , Female , Glioblastoma/drug therapy , Humans , Male , Middle Aged , Myasthenia Gravis/physiopathology , Neuromuscular Diseases/chemically induced , Neuromuscular Junction/physiopathology , Piperazines/administration & dosage , Protein Kinase Inhibitors/administration & dosage , Quinazolines/administration & dosage , Syndrome
3.
Neurology ; 73(15): 1200-6, 2009 Oct 13.
Article in English | MEDLINE | ID: mdl-19822869

ABSTRACT

BACKGROUND: Bevacizumab has recently been approved by the US Food and Drug Administration for recurrent glioblastoma (GBM). However, patterns of relapse, prognosis, and outcome of further therapy after bevacizumab failure have not been studied systematically. METHODS: We identified patients at Memorial Sloan-Kettering Cancer Center with recurrent GBM who discontinued bevacizumab because of progressive disease. RESULTS: There were 37 patients (26 men with a median age of 54 years). The most common therapies administered concurrently with bevacizumab were irinotecan (43%) and hypofractionated reirradiation (38%). The median overall survival (OS) after progressive disease on bevacizumab was 4.5 months; 34 patients died. At the time bevacizumab was discontinued for tumor progression, 17 patients (46%) had an increase in the size of enhancement at the initial site of disease (local recurrence), 6 (16%) had a new enhancing lesion outside of the initial site of disease (multifocal), and 13 (35%) had progression of predominantly nonenhancing tumor. Factors associated with shorter OS after discontinuing bevacizumab were lower performance status and nonenhancing pattern of recurrence. Additional salvage chemotherapy after bevacizumab failure was given to 19 patients. The median progression-free survival (PFS) among these 19 patients was 2 months, the median OS was 5.2 months, and the 6-month PFS rate was 0%. CONCLUSIONS: Contrast enhanced MRI does not adequately assess disease status during bevacizumab therapy for recurrent glioblastoma (GBM). A nonenhancing tumor pattern of progression is common after treatment with bevacizumab for GBM and is correlated with worse survival. Treatments after bevacizumab failure provide only transient tumor control.


Subject(s)
Angiogenesis Inhibitors/therapeutic use , Antibodies, Monoclonal/therapeutic use , Brain Neoplasms/drug therapy , Drug Resistance, Neoplasm/drug effects , Glioblastoma/drug therapy , Adult , Aged , Antibodies, Monoclonal, Humanized , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Bevacizumab , Brain Neoplasms/mortality , Brain Neoplasms/therapy , Disease-Free Survival , Female , Glioblastoma/mortality , Glioblastoma/therapy , Humans , Male , Middle Aged , Neoplasm Metastasis , Neoplasm Recurrence, Local , Prognosis , Retrospective Studies , Salvage Therapy , Treatment Failure
4.
Neurology ; 71(17): 1355-60, 2008 Oct 21.
Article in English | MEDLINE | ID: mdl-18936428

ABSTRACT

OBJECTIVE: To describe the demographics, diagnostic details, therapeutic management, and outcome in patients with primary CNS lymphoma (PCNSL) with ocular involvement. METHODS: A retrospective study of 221 patients was assembled from 16 centers in seven countries. Only HIV-negative, immunocompetent patients with brain and ocular lymphoma were included; none had systemic lymphoma. RESULTS: Median age at diagnosis was 60. Fifty-seven percent were women. Median Eastern Cooperative Oncology Group performance status was 2. Ocular disturbance and behavioral/cognitive changes were the most common presenting symptoms. Diagnosis of lymphoma was made by brain biopsy (147), vitrectomy (65), or CSF cytology (11). Diagnosis of intraocular lymphoma was made by vitrectomy/choroidal/retinal biopsy (90) or clinical ophthalmic examination (141). CSF cytology was positive in 23%. Treatment information was available for 176 patients. A total of 102 received dedicated ocular therapy (ocular radiotherapy 79, intravitreal methotrexate 22, and both 1) in addition to treatment for their brain lymphoma. Sixty-nine percent progressed at a median of 13 months; sites of progression included brain 52%, eyes 19%, brain and eyes 12%, and systemic 2%. Patients treated with local ocular therapy did not have a statistically significant decreased risk of failing in the eyes (p = 0.7). Median progression free survival and overall survival for the entire cohort were 18 and 31 months. CONCLUSION: This is the largest reported series of primary CNS lymphoma (PCNSL) with intraocular involvement. Progression free and overall survival was similar to that reported with PCNSL. Dedicated ocular therapy improved disease control but did not affect overall survival.


Subject(s)
Central Nervous System Neoplasms/epidemiology , Cooperative Behavior , Eye Neoplasms/epidemiology , Lymphoma/epidemiology , Adolescent , Adult , Aged , Aged, 80 and over , Central Nervous System Neoplasms/complications , Central Nervous System Neoplasms/therapy , Eye Neoplasms/complications , Eye Neoplasms/therapy , Female , Follow-Up Studies , Humans , Internationality , Lymphoma/complications , Lymphoma/therapy , Male , Middle Aged , Research/trends , Retrospective Studies , Survival Rate/trends
5.
J Postgrad Med ; 54(3): 203-5, 2008.
Article in English | MEDLINE | ID: mdl-18626168

ABSTRACT

BACKGROUND: Central nervous system fungal infections (FI) are important complications and a cause of mortality in patients who receive hematopoietic stem cell transplantation (HSCT). AIMS: To study the clinical aspects of fungal encephalitis (FE). SETTINGS AND DESIGN: The study was carried out at the HSCT Center of the Hospital de Clínicas, Federal University of Paraná, Curitiba, Brazil. MATERIALS AND METHODS: Clinical records and autopsy reports from patients submitted to HSCT with a diagnosis of FE. RESULTS: Twelve patients were diagnosed with FE presenting with lowered level of consciousness, hemiparesis and seizures. We were able to identify two subgroups regarding susceptibility to FE: (1) patients with early onset FI and severe leucopenia, and (2) patients with later onset FI with graft-versus-host disease using immunosuppressive drugs. Eleven of the patients died directly due to the neurological complication, all had post-mortem confirmation of the diagnosis of FI. CONCLUSIONS: These clinical, paraclinical and temporal patterns may provide the opportunity for earlier diagnosis and interventions.


Subject(s)
Central Nervous System Fungal Infections/etiology , Encephalitis/complications , Graft vs Host Disease/etiology , Hematopoietic Stem Cell Transplantation/adverse effects , Transplantation Conditioning/adverse effects , Adolescent , Adult , Brazil , Central Nervous System Fungal Infections/complications , Central Nervous System Fungal Infections/immunology , Child , Child, Preschool , Encephalitis/immunology , Female , Graft vs Host Disease/immunology , Graft vs Host Disease/mortality , Humans , Male , Middle Aged , Prognosis , Retrospective Studies , Young Adult
6.
Arq Neuropsiquiatr ; 59(3-B): 722-4, 2001 Sep.
Article in English | MEDLINE | ID: mdl-11593272

ABSTRACT

A missense G209A mutation of the alpha-synuclein gene was recently described in a large Contursi kindred with Parkinson's disease (PD). The objective of this study is to determine if the mutation G209A of the alpha-synuclein gene was present in 10 Brazilian families with PD. PD patients were recruited from movement disorders clinics of Brazil. A family history with two or more affected in relatives was the inclusion criterion for this study. The alpha-synuclein G209A mutation assay was made using polymerase chain reaction and the restriction enzyme Tsp45I. Ten patients from 10 unrelated families were studied. The mean age of PD onset was 42.7 years old. We did not find the G209A mutation in our 10 families with PD. Our results suggest that alpha-synuclein mutation G209A is uncommon in Brazilian PD families.


Subject(s)
Mutation/genetics , Nerve Tissue Proteins/genetics , Parkinson Disease/genetics , Adult , Age of Onset , Aged , Brazil , Female , Humans , Male , Middle Aged , Pedigree , Polymerase Chain Reaction , Restriction Mapping , Synucleins , alpha-Synuclein
7.
Arq Neuropsiquiatr ; 59(3-B): 740-5, 2001 Sep.
Article in Portuguese | MEDLINE | ID: mdl-11593276

ABSTRACT

We retrospectively analyzed the epidemiological features of 164 out-clinic patients with a first-onset stroke between 15 and 49 years old. Ischemic stroke occurred in 141 patients, hemorrhagic stroke in 16 patients, and venous thrombosis in 7 patients. Forty-eight percent of ischemic strokes were atherothrombotic, but no etiology was found in 32% of patients with ischemic stroke. Systemic arterial hypertension was the most frequent etiology in the hemorrhagic stroke group. The most frequent risk factors were systemic arterial hypertension, smoking, hypercholesterolemia, alcoholism and diabetes mellitus. Although stroke in young adults deserves some specific etiological investigation, we found that ordinary risk factors such as hypertension, tobacco use, hypercholesteremia and diabetes were prevalent in our population. It seems that prevention campaigns should be the target of our work.


Subject(s)
Stroke/epidemiology , Adolescent , Adult , Brazil/epidemiology , Female , Humans , Intracranial Embolism and Thrombosis/complications , Male , Middle Aged , Prevalence , Retrospective Studies , Risk Factors , Stroke/etiology
8.
Arq Neuropsiquiatr ; 59(3-B): 790-2, 2001 Sep.
Article in English | MEDLINE | ID: mdl-11593284

ABSTRACT

Autosomal recessive hereditary spastic paraplegia (AR-HSP) associated with thin corpus callosum was recently described in Japan, and most families were linked to chromosome 15 q13-15. We report two patients from two different Brazilian families with progressive gait disturbance starting at the second decade of life, spastic paraparesis, and mental deterioration. One patient presented cerebellar ataxia. Magnetic resonance imaging (MRI) of the head of both patients showed a thin corpus callosum. AR-HSP with a thin corpus callosum is a rare disorder, mainly described in Japanese patients. We found only 4 Caucasian families with AR-HSP with thin corpus callosum described in the literature. Further studies including additional Caucasian families of AR-HSP with thin corpus callosum are required to delineate the genetic profile of this syndrome in occidental countries.


Subject(s)
Agenesis of Corpus Callosum , Spastic Paraplegia, Hereditary/genetics , Adolescent , Brazil , Corpus Callosum/pathology , Female , Humans , Magnetic Resonance Imaging , Male , Spastic Paraplegia, Hereditary/diagnosis , Spastic Paraplegia, Hereditary/pathology , White People
9.
Arq Neuropsiquiatr ; 59(3-B): 809-11, 2001 Sep.
Article in English | MEDLINE | ID: mdl-11593289

ABSTRACT

Machado-Joseph disease (MJD) is the most common autosomal dominant spinocerebellar ataxia and presents great phenotypic variability. MJD presenting with spastic paraparesis was recently described in Japanese patients. We report the case of 41-year-old woman with the phenotype of complicated hereditary spastic paraplegia. Her father died at the age of 56 years due to an undiagnosed progressive neurological disease that presented parkinsonism. She had an expanded allele with 66 CAG repeats and a normal allele with 22 repeats in the gene of MJD. MJD should be considered in the differential diagnosis of autosomal dominant complicated HSP. A patient with the phenotype of complicated HSP and relatives with other clinical features of a neurodegenerative disease should raise the suspicion of MJD.


Subject(s)
Machado-Joseph Disease/genetics , Spastic Paraplegia, Hereditary/genetics , Adult , Diagnosis, Differential , Female , Humans , Machado-Joseph Disease/complications , Machado-Joseph Disease/diagnosis , Pedigree , Phenotype , Spastic Paraplegia, Hereditary/complications
10.
Arq Neuropsiquiatr ; 59(3-A): 616-8, 2001 Sep.
Article in Portuguese | MEDLINE | ID: mdl-11588648

ABSTRACT

Acute cerebellitis can occur in association with varicella-zoster virus, enterovirus, mumps, mycoplasma, and other infective organisms. Acute cerebellitis is a rare complication of Epstein-Barr virus (EBV) infection. We report the case of a 21-year-old woman with a 12-day history of nausea and vomiting, gait and limbs ataxia, myoclonus, tremor of head and all four limbs, opsoclonus and cutaneous rash. Anti-EBV IgG and IgM antibodies against antiviral capsid were positive and anti-EBV against virus-associated nuclear antigen was also positive. EBV infection in association with neurological findings can occur without the classic signs and symptoms of infectious mononucleosis.


Subject(s)
Cerebellar Diseases/virology , Encephalitis, Viral/complications , Epstein-Barr Virus Infections/complications , Herpesvirus 4, Human/isolation & purification , Acute Disease , Adult , Anti-Inflammatory Agents/therapeutic use , Antibodies, Viral/isolation & purification , Cerebellar Diseases/drug therapy , Dexamethasone/therapeutic use , Encephalitis, Viral/drug therapy , Epstein-Barr Virus Infections/drug therapy , Female , Herpesvirus 4, Human/immunology , Humans
11.
Arq Neuropsiquiatr ; 59(3-A): 633-6, 2001 Sep.
Article in Portuguese | MEDLINE | ID: mdl-11588652

ABSTRACT

Charcot described many neurological diseases in the 19th century, particularly in movement disorders. Charcot contributed in the clinical description of Parkinson's disease, and introduced its first pharmacological treatment. He also studied the hyperkinesias, e.g. of Tourette syndrome, differential diagnosis of tremors, dystonias, choreas and startle disease. Marsden, who died recently, was an exponent in the study of Movement Disorders, with many publications in this field in the 20th century. His most important contributions are definitions and classifications of movement disorders, such as Parkinson's disease, dystonia, myoclonus, essential tremor, the description of the syndromes "Painful Legs Moving Toes", "Gait Ignition Failure" and "Primary Writing Tremor". The contributions of Charcot in the 19th century and Marsden in the 20th century to the movement disorders allow us to conclude that both of them were the most representative icons in this field in the past two centuries.


Subject(s)
Movement Disorders/history , History, 19th Century , History, 20th Century , Humans
12.
Arq Neuropsiquiatr ; 59(2-B): 347-52, 2001 Jun.
Article in English | MEDLINE | ID: mdl-11460177

ABSTRACT

We report on the clinical course and histopathologic muscle alterations of five patients diagnosed with neurosarcoidosis, who underwent biopsy due to their muscle manifestations. The five patients were females and only one was less than 40 years of age. Proximal muscle weakness was presented by all and only two patients complained of myalgia. Only normal values of serum muscle enzymes were detected. Electromyography revealed diverse findings such as normal, myopathic and neuropathic patterns. Granuloma was not present in one muscle biopsy. Two patients thoroughly recovered by taking only prednisone and one patient required a methotrexate addition for 3 months before becoming asymptomatic. The other two patients received azathioprine, one due to steroid side effects but without a satisfactory evolution, and the other to strengthen the prednisone régime, with excellent results.


Subject(s)
Central Nervous System Diseases/pathology , Muscular Diseases/pathology , Sarcoidosis/pathology , Adolescent , Adult , Anti-Inflammatory Agents/therapeutic use , Biopsy , Central Nervous System Diseases/drug therapy , Central Nervous System Diseases/physiopathology , Female , Humans , Middle Aged , Muscle Weakness/diagnosis , Muscular Diseases/physiopathology , Prednisone/therapeutic use , Sarcoidosis/drug therapy , Sarcoidosis/physiopathology
13.
Arq Neuropsiquiatr ; 59(2-A): 259-62, 2001 Jun.
Article in English | MEDLINE | ID: mdl-11400038

ABSTRACT

We report the case of a 3-(1/2)-year-old girl with hypotonia, multiple joint contractures, hip luxation, arachnodactyly, adducted thumbs, dolichostenomelia, and abnormal external ears suggesting the diagnosis of congenital contractural arachnodactyly (CCA). The serum muscle enzymes were normal and the needle electromyography showed active and chronic denervation. The muscle biopsy demonstrated active and chronic denervation compatible with spinal muscular atrophy. Analysis of exons 7 and 8 of survival motor neuron gene through polymerase chain reaction did not show deletions. Neurogenic muscular atrophy is a new abnormality associated with CCA, suggesting that CCA is clinically heterogeneous.


Subject(s)
Contracture/congenital , Marfan Syndrome/genetics , Child, Preschool , Contracture/complications , Exons , Female , Humans , Marfan Syndrome/complications , Muscular Atrophy/complications , Muscular Atrophy/congenital , Muscular Atrophy/pathology
14.
Arq Neuropsiquiatr ; 58(3B): 789-99, 2000 Sep.
Article in English | MEDLINE | ID: mdl-11018813

ABSTRACT

UNLABELLED: Patients with dermatomyositis (DM) or polymyositis (PM) were studied retrospectively. The patients were divided into four groups: definite PM 24, probable PM 19, definite DM 34 and mild-early DM 25 cases. PM patients complained more often proximal muscle weakness [p <0.01]. DM patients complained more arthralgia [p <0.05], dysphagia [p <0.03] and weight loss [p <0.04]. Five patients had a malignant neoplasm and 9 had other connective-tissue disease. DM presented higher ESR than PM [p <0.002]. PM presented more significant increase in creatine kinase (CK) [p <0.02] and in alanine aminotransferase (ALT) [p <0.001] levels. Electromyography showed myopathic pattern in 76%. Muscle biopsy was the definitive test. Perifascicular atrophy was more frequent in definite DM than in mild-early DM group [p <0.03]. CONCLUSION: A small association with connective-tissue diseases and neoplasms was found. DM and PM are clinically different. DM presents systemic involvement affecting the skin, developing more severe arthralgia, dysphagia and weight loss and presenting higher values of ESR. PM presents a restricted and more significant involvement of muscles generating more weakness complaints and higher levels of serum muscle enzymes.


Subject(s)
Dermatomyositis/diagnosis , Polymyositis/diagnosis , Adolescent , Adult , Aged , Aged, 80 and over , Alanine Transaminase/blood , Biopsy , Blood Sedimentation , Child , Child, Preschool , Creatine Kinase/blood , Dermatomyositis/blood , Dermatomyositis/complications , Electromyography , Female , Humans , Infant , Infant, Newborn , Male , Middle Aged , Polymyositis/blood , Polymyositis/complications , Retrospective Studies
15.
Muscle Nerve ; 23(10): 1582-5, 2000 Oct.
Article in English | MEDLINE | ID: mdl-11003795

ABSTRACT

We report the case of a 37-year-old man with clinical and electrophysiological features of hereditary slow-channel syndrome (SCS) and antibodies against acetylcholine receptors (AChR-Abs). He presented with weakness of shoulder and hand muscles. A supramaximal single stimulus to the motor nerves disclosed a double compound muscle action potential (CMAP). Repetitive stimulation of ulnar, suprascapular, and median nerves showed a CMAP decrement greater than 10%. The patient responded to pyridostigmine. This report confirms the importance of AChR-Ab titers in suspected cases of hereditary SCS because patients with positive AChR-Abs may have a better response to available treatments.


Subject(s)
Muscles/physiopathology , Myasthenic Syndromes, Congenital/physiopathology , Adult , Humans , Male , Neural Conduction/physiology
16.
Arq Neuropsiquiatr ; 57(2B): 484-8, 1999 Jun.
Article in English | MEDLINE | ID: mdl-10450358

ABSTRACT

Neurofibromatosis type 1 (NF1) can virtually affect any organ, presenting most frequently with "cafe au lait" spots and neurofibromas. Vasculopathy is a known complication of NF1, but cerebrovascular disease is rare. We report the case of a 51-year-old man admitted to the hospital with a history of stroke four months before admission. On physical examination, he presented various "cafe au lait" spots and cutaneous neurofibromas. Neurologic examination demonstrated right-sided facial paralysis, right-sided hemiplegia, and aphasia. Computed tomography scan of head showed hypodense areas in the basal ganglia and centrum semiovale. Radiographs of cranium and cervical spine showed basilar impression. Angiography revealed complete occlusion of both vertebral and left internal carotid arteries, and partial stenosis of the right internal carotid artery. A large network of collateral vessels was present (moyamoya syndrome). It is an uncommon case of occlusive cerebrovascular disease associated with NF1, since most cases described in the literature are in young people, and tend to spare the posterior cerebral circulation. Basilar impression associated with this case may be considered a pure coincidence, but rare cases of basilar impression and NF1 have been described.


Subject(s)
Cerebrovascular Disorders/etiology , Neurofibromatosis 1/complications , Platybasia/etiology , Cerebrovascular Disorders/diagnosis , Humans , Male , Middle Aged , Moyamoya Disease , Neurofibromatosis 1/diagnosis , Platybasia/diagnosis , Syndrome
17.
Arq Neuropsiquiatr ; 57(3A): 659-65, 1999 Sep.
Article in Portuguese | MEDLINE | ID: mdl-10667293

ABSTRACT

True neurogenic thoracic outlet syndrome is caused by compression of the lower trunk of the brachial plexus usually by a cervical rib, fibrous band or an elongated transverse process of C7. We describe two cases of female patients (23 and 19 years old) with pain in the right superior limb and progressive muscular weakness and atrophy of the intrinsic muscles of hand. Electrodiagnostic studies showed reduced amplitude of compound muscle action potential of median nerve and decreased amplitude of ulnar sensory nerve action potential. Motor and sensory nerve conduction velocities were normal in both patients. Needle electromyography were findings compatible with chronic denervation in the intrinsic muscles of the right hand of both patients. Radiological investigation showed cervical ribs in one case and elongated transverse process of C7 in the other. A discussion about the clinical and electrophysiological features and the treatment of the syndrome was performed.


Subject(s)
Thoracic Outlet Syndrome/diagnosis , Adult , Diagnosis, Differential , Electromyography , Female , Humans , Muscular Atrophy/pathology , Neural Conduction/physiology , Thoracic Outlet Syndrome/pathology , Thoracic Outlet Syndrome/physiopathology
18.
Arq Neuropsiquiatr ; 56(3A): 388-97, 1998 Sep.
Article in Portuguese | MEDLINE | ID: mdl-9754419

ABSTRACT

Among 1400 muscle biopsies, we found 16 cases with rimmed vacuoles whose diagnosis were sporadic inclusion body myositis (IBM) (4 cases), juvenile spinal muscular atrophy (6 cases), distal myopathies (3 cases), limb-girdle muscular dystrophy (2 cases), and peripheral neuropathy (1 case). Monoclonal antibodies reactive for T lymphocytes and subsets, B lymphocytes, macrophages, natural killer cells, immunoglobulins, and complement were used to analyze the inflammatory infiltrate. The analysis was quantitative and according to the site of accumulation (interstitial, endomysial, and perivascular). The immunocytochemical analysis showed CD8+ lymphocytes in the interstitial in most cases, occasionally inside of muscle fibers, and rarely in the perivascular region. The IBM cases had an increased number of CD8+ lymphocytes comparing with the other diseases. CD8+/CD4+ ratio was increased in IBM compared with the other diseases. Macrophages were frequent in IBM, distal myopathy, and one case of limb-girdle muscular dystrophy. Natural killer cells were frequent at interstitial.


Subject(s)
Myositis, Inclusion Body/pathology , Neuromuscular Diseases/pathology , Adolescent , Adult , Aged , Child , Female , Humans , Immunohistochemistry , Lymphocytes/chemistry , Macrophages/chemistry , Middle Aged , Spinal Muscular Atrophies of Childhood/pathology , Vacuoles
19.
Arq Neuropsiquiatr ; 56(3A): 457-64, 1998 Sep.
Article in English | MEDLINE | ID: mdl-9754429

ABSTRACT

Two cases of Lambert-Eaton myasthenic syndrome, in female patients whose neoplasm investigation was negative, are reported. Repetitive stimulation of ulnar nerve showed an incremental response (+187% and +198%). Needle EMG was normal in one of them, however, the other patient showed fibrillation potentials, positive sharp waves, potentials of low amplitude and short duration. The authors discuss the clinical, electrophysiological, and pathological features of the disease, as well as some aspects of the treatment and follow-up of these patients.


Subject(s)
Lambert-Eaton Myasthenic Syndrome/pathology , Adult , Autoantibodies/blood , Electromyography , Female , Humans , Lambert-Eaton Myasthenic Syndrome/immunology , Middle Aged
20.
Arq Neuropsiquiatr ; 56(3A): 480-5, 1998 Sep.
Article in Portuguese | MEDLINE | ID: mdl-9754433

ABSTRACT

Ossification of the posterior longitudinal ligament (OPLL) is an uncommon cause of compressive myelopathy in the Caucasian population. A case of spastic paraparesis in a Caucasian man whose radiological investigation showed OPLL is presented. The radiographs of the cervical spine showed a strip of bony density posterior to the vertebral bodies, extending from C2 to T1. Computerized tomography (CT) and CT myelography showed OPLL at the same level. Magnetic resonance showed an area of increased signal on T2-weighted sequences at C7-T1 level suggestive of myelomalacia. The patient underwent an open-door laminoplasty (C2 to C7) with improvement of the paraparesis. OPLL should be included in the differential diagnosis of cervical myelopathy. It can be easily detected by plain radiographs and CT of the cervical spine. A review of the clinical and radiological features and the treatment of OPLL is presented.


Subject(s)
Ossification of Posterior Longitudinal Ligament/complications , Paraparesis, Tropical Spastic/etiology , Spinal Cord Compression , Humans , Male , Middle Aged , Myelography , Ossification of Posterior Longitudinal Ligament/surgery , Spinal Cord/diagnostic imaging
SELECTION OF CITATIONS
SEARCH DETAIL
...